MD
Pediatrix Medical Group, Inc.
25.80$
+0.1%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 12.9% | 11.6% | 11.0% | 10.7% | 11.1% | 17.6% | 46.3% | 30.9% | 18.2% | 21.8% | 29.7% | 34.0% | |
| 1.3% | 1.1% | 1.0% | 1.0% | 0.6% | 2.6% | 33.6% | 14.2% | 0.4% | 3.3% | 10.7% | 16.7% | |
| 1.5% | 1.3% | 1.3% | 1.2% | 1.0% | 4.4% | 36.7% | 17.9% | 4.4% | 8.0% | 16.2% | 22.2% | |
| 9.8% | 9.8% | 9.3% | 8.6% | 8.5% | 10.5% | 7.2% | 11.6% | 12.6% | 12.6% | 12.7% | 10.8% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.6% | – | – | |
| 1.8% | 1.8% | 1.9% | 2.1% | 2.2% | 3.1% | 2.3% | 2.6% | 3.1% | 6.6% | 3.6% | 3.3% | |
| 76.9% | 74.0% | 76.5% | 78.4% | 79.0% | 35.7% | 44.1% | 55.3% | 65.3% | 62.4% | 57.7% | 56.1% | |
| 5.5% | 9.3% | 12.5% | 10.9% | 9.9% | 0.7% | 0.8% | 0.8% | 0.8% | 1.0% | 0.5% | 0.8% | |
| 37.2% | 46.4% | 48.3% | 47.7% | 48.0% | 63.8% | 77.7% | 67.1% | 62.0% | 61.8% | 64.5% | 61.5% | |
| 10.5% | 8.7% | 7.6% | 7.5% | 7.9% | 13.1% | 13.3% | 15.7% | 18.2% | 17.5% | 20.2% | 20.4% | |
| 0.3% | 0.3% | 0.5% | 0.0% | 0.0% | 0.4% | 0.6% | 0.8% | 1.6% | 1.6% | 1.5% | 1.7% | |
| 0.9% | 0.5% | 0.5% | 0.6% | 0.5% | 0.9% | 1.8% | 1.3% | 1.4% | 1.6% | 2.2% | 1.7% | |
| 10.2% | 27.8% | 31.5% | 31.6% | 33.3% | 41.7% | 52.0% | 36.8% | 27.1% | 27.6% | 27.6% | 25.3% | |
| 62.8% | 53.6% | 51.7% | 52.3% | 52.0% | 36.2% | 22.3% | 32.9% | 38.0% | 38.2% | 35.5% | 38.5% | |
| 38.2% | 33.2% | 33.4% | 34.9% | 35.3% | 12.3% | -8.6% | -5.7% | -3.8% | -6.7% | -11.5% | -3.7% | |
| 2.8% | 2.1% | 1.8% | 1.6% | 1.5% | 2.0% | 2.6% | 3.2% | 3.6% | 3.7% | 3.9% | 3.8% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.